Dipartimento di Medicina e Chirurgia (School of Medicine and Surgery), University of Milan-Bicocca, Milan, Italy.
Milan Center for Neuroscience (NeuroMI), University of Milan-Bicocca, Milan, Italy.
Restor Neurol Neurosci. 2020;38(3):239-250. doi: 10.3233/RNN-190948.
Around 253 million people worldwide suffer from irreversible visual damage. Numerous studies have been carried out in order to unveil the effects of electrical stimulation (ES) as a useful tool for rehabilitation for different visual conditions and pathologies.
This systematic review aimed to 1) examine the current evidence of ES efficacy for the treatment of visual pathologies and 2) define the corresponding degree of the recommendation of different ES techniques.
A systematic review was conducted in MEDLINE and Cochrane Library database to collect documents published between 2000 and 2018. For each study, Level of Evidence of Effectiveness of ES as well as the Class of Quality for the treatment of different visual pathologies were determined.
Thirty-eight articles were included. Studies were grouped according to the pathology treated and the type of stimulation administered. The first group included studies treating pre-chiasmatic pathologies (age-related macular degeneration, macular dystrophy, retinal artery occlusion, retinitis pigmentosa, glaucoma, optic nerve damage, and optic neuropathy) using pre-chiasmatic stimulation; the second group included studies treating both pre-chiasmatic pathologies (amblyopia, myopia) and post-chiasmatic pathologies or brain conditions (hemianopsia, brain trauma) by means of post-chiasmatic stimulation. In the first group, repetitive transorbital alternating current stimulation (rtACS) reached level A recommendation, and transcorneal electrical stimulation (tcES) reached level B. In the second group, both high-frequency random noise stimulation (hf-RNS) and transcranial direct current stimulation (tDCS) reached level C recommendation.
Study's findings suggest conclusive evidence for rtACS treatment. For other protocols results are promising but not conclusive since the examined studies assessed different stimulation parameters and endpoints. A comparison of the effects of different combinations of these variables still lacks in the literature. Further studies are needed to optimize existing protocols and determine if different protocols are needed for different diseases.
全球约有 2.53 亿人患有不可逆转的视力损伤。为了揭示电刺激(ES)作为不同视觉状况和病理的康复有用工具的效果,已经进行了许多研究。
本系统评价旨在 1)检查 ES 治疗视觉病变的疗效的现有证据,2)确定不同 ES 技术的相应推荐程度。
在 MEDLINE 和 Cochrane 图书馆数据库中进行了系统评价,以收集 2000 年至 2018 年期间发表的文献。对于每项研究,确定 ES 疗效的有效性证据水平以及治疗不同视觉病变的治疗质量等级。
共纳入 38 篇文章。根据治疗的病理和给予的刺激类型对研究进行分组。第一组包括使用视交叉前刺激治疗视交叉前病变(年龄相关性黄斑变性、黄斑营养不良、视网膜动脉阻塞、视网膜色素变性、青光眼、视神经损伤和视神经病变)的研究;第二组包括通过视交叉后刺激治疗视交叉前病变(弱视、近视)和视交叉后病变或脑部疾病(偏盲、脑外伤)的研究。在第一组中,重复经颅交流电刺激(rtACS)达到 A 级推荐,经角膜电刺激(tcES)达到 B 级推荐。在第二组中,高频随机噪声刺激(hf-RNS)和经颅直流电刺激(tDCS)均达到 C 级推荐。
研究结果表明 rtACS 治疗具有确凿的证据。对于其他方案,结果是有希望的,但没有定论,因为所检查的研究评估了不同的刺激参数和终点。这些变量的不同组合的效果比较在文献中仍然缺乏。需要进一步的研究来优化现有的方案,并确定是否需要针对不同疾病采用不同的方案。